Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 4998 | 1620 | 33.7 | 50% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | GLIMEPIRIDE | Author keyword | 14 | 21% | 4% | 61 |
| 2 | JTT 608 | Author keyword | 9 | 83% | 0% | 5 |
| 3 | SECONDARY FAILURE | Author keyword | 9 | 44% | 1% | 15 |
| 4 | HOE 490 | Author keyword | 4 | 75% | 0% | 3 |
| 5 | GLUCAGON TEST | Author keyword | 4 | 38% | 0% | 8 |
| 6 | GLICLAZIDE | Author keyword | 4 | 11% | 2% | 32 |
| 7 | CAS 93479 97 1 | Author keyword | 3 | 57% | 0% | 4 |
| 8 | INSULIN REQUIRING DIABETES | Author keyword | 3 | 57% | 0% | 4 |
| 9 | SULPHONYLUREA DERIVATIVES | Author keyword | 3 | 60% | 0% | 3 |
| 10 | GLIPIZIDE | Author keyword | 2 | 11% | 1% | 20 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | GLIMEPIRIDE | 14 | 21% | 4% | 61 | Search GLIMEPIRIDE | Search GLIMEPIRIDE |
| 2 | JTT 608 | 9 | 83% | 0% | 5 | Search JTT+608 | Search JTT+608 |
| 3 | SECONDARY FAILURE | 9 | 44% | 1% | 15 | Search SECONDARY+FAILURE | Search SECONDARY+FAILURE |
| 4 | HOE 490 | 4 | 75% | 0% | 3 | Search HOE+490 | Search HOE+490 |
| 5 | GLUCAGON TEST | 4 | 38% | 0% | 8 | Search GLUCAGON+TEST | Search GLUCAGON+TEST |
| 6 | GLICLAZIDE | 4 | 11% | 2% | 32 | Search GLICLAZIDE | Search GLICLAZIDE |
| 7 | CAS 93479 97 1 | 3 | 57% | 0% | 4 | Search CAS+93479+97+1 | Search CAS+93479+97+1 |
| 8 | INSULIN REQUIRING DIABETES | 3 | 57% | 0% | 4 | Search INSULIN+REQUIRING+DIABETES | Search INSULIN+REQUIRING+DIABETES |
| 9 | SULPHONYLUREA DERIVATIVES | 3 | 60% | 0% | 3 | Search SULPHONYLUREA+DERIVATIVES | Search SULPHONYLUREA+DERIVATIVES |
| 10 | GLIPIZIDE | 2 | 11% | 1% | 20 | Search GLIPIZIDE | Search GLIPIZIDE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SECONDARY FAILURE | 26 | 41% | 3% | 49 |
| 2 | GLIPIZIDE | 20 | 34% | 3% | 48 |
| 3 | SULFONYLUREA THERAPY | 18 | 32% | 3% | 47 |
| 4 | GLYBURIDE | 12 | 18% | 4% | 64 |
| 5 | ORAL HYPOGLYCEMIC AGENTS | 8 | 19% | 2% | 40 |
| 6 | CELL SULFONYLUREA RECEPTOR | 7 | 67% | 0% | 6 |
| 7 | CHRONIC SULFONYLUREA THERAPY | 6 | 100% | 0% | 4 |
| 8 | SECONDARY SULFONYLUREA FAILURE | 6 | 50% | 0% | 8 |
| 9 | GLYBURIDE THERAPY | 5 | 60% | 0% | 6 |
| 10 | BEDTIME NPH INSULIN | 5 | 23% | 1% | 18 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| SULFONYLUREAS IN NIDDM | 1992 | 325 | 116 | 62% |
| GLICLAZIDE - AN UPDATE OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS | 1993 | 118 | 81 | 60% |
| DRUG-THERAPY - ORAL HYPOGLYCEMIC AGENTS | 1989 | 389 | 149 | 60% |
| GLUCOSE TOXICITY | 1990 | 624 | 130 | 26% |
| INSULIN PLUS A SULFONYLUREA AGENT FOR TREATING TYPE-2 DIABETES | 1991 | 55 | 46 | 89% |
| The clinical utility of C-peptide measurement in the care of patients with diabetes | 2013 | 21 | 112 | 42% |
| Estimating the effect of sulfonylurea on HbA(1c) in diabetes: a systematic review and meta-analysis | 2013 | 14 | 47 | 49% |
| The role of sulphonylureas in the management of type 2 diabetes mellitus | 2004 | 127 | 266 | 31% |
| Glimepiride: Role of a new sulfonylurea in the treatment of type 2 diabetes mellitus | 1998 | 39 | 27 | 63% |
| C-PEPTIDE AS A MEASURE OF THE SECRETION AND HEPATIC EXTRACTION OF INSULIN - PITFALLS AND LIMITATIONS | 1984 | 381 | 14 | 86% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SERV ENDOCRINOL EXPT | 1 | 50% | 0.1% | 2 |
| 2 | PENINSULA NIHR CLIN IL | 1 | 17% | 0.4% | 6 |
| 3 | MALMO GEN HOSP CLIN PHARMACOL | 1 | 33% | 0.1% | 2 |
| 4 | CENT HOSP PSYCHIAT | 1 | 50% | 0.1% | 1 |
| 5 | CENTRAL PHARMACEUT | 1 | 50% | 0.1% | 1 |
| 6 | CV NOORDEN KLIN | 1 | 50% | 0.1% | 1 |
| 7 | ENDOCRINOL DIABET SECT 111A | 1 | 50% | 0.1% | 1 |
| 8 | ENFERMEDADES METAB ENDOCRINOL REUMATOL | 1 | 50% | 0.1% | 1 |
| 9 | HUDDINGE HOSP PHARM | 1 | 50% | 0.1% | 1 |
| 10 | MASSACHUSETTS GEN HOSP MED DIABET | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000235959 | GLICLAZIDE//INTERNAL MED DIABETOL CLIN PHARMACOL//DRUG QUAL CONTROL PHARMACOVIGILANC |
| 2 | 0.0000181716 | PLACENTAL INSULIN RECEPTORS//DIABET BRANCH BLDG 10 ROOM 8 S 243//HLTH SCI BIOMATH |
| 3 | 0.0000175368 | NATEGLINIDE//KAD 1229//REPAGLINIDE |
| 4 | 0.0000168981 | C PEPTICLE//CLIN PHYSIOL METAB UNIT//HENRY WELLCOME S EGRATED CELL SIGNALLING |
| 5 | 0.0000140310 | METFORMIN HYDROCHLORIDE//PIOGLITAZONE HYDROCHLORIDE//ROSIGLITAZONE MALEATE |
| 6 | 0.0000138728 | METFORMIN//LACTIC ACIDOSIS//METFORMIN ASSOCIATED LACTIC ACIDOSIS |
| 7 | 0.0000118725 | GLUCOSE EFFECTIVENESS//INTRAVENOUS GLUCOSE TOLERANCE TEST//MINIMAL MODEL |
| 8 | 0.0000101818 | PROINSULIN//INTACT PROINSULIN//SPLIT PROINSULIN |
| 9 | 0.0000096690 | GLIBORNURIDE//MALMO GEN HOSP ENDOCRINOL//ALCOHOL TOLERANCE |
| 10 | 0.0000092745 | PROINSULIN C PEPTIDE//C PEPTIDE//HUMAN C PEPTIDE |